Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20688898.
- Also identified by DOI 10.1158/1078-0432.CCR-10-0356 and PMC identifier 3393131.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wnt ligands are lipid-modified secreted glycoproteins that regulate embryonic development, cell fate specification, and the homeostasis of self-renewing adult tissues. In addition to its well-established role in thymocyte development, recent studies have indicated that Wnt/β-catenin signaling is critical for the differentiation, polarization, and survival of mature T lymphocytes. Here, we describe our current understanding of Wnt signaling in the biology of post-thymic T cells, and discuss how harnessing the Wnt/β-catenin pathway might improve the efficacy of vaccines, T-cell-based therapies, and allogeneic stem cell transplantation for the treatment of patients with cancer.
Medical subject headings
- Immunotherapy
- Neoplasms
- Signal Transduction
- T-Lymphocytes
- Wnt Proteins
- beta Catenin